COVID-19 and comorbidities of hepatic diseases in a global perspective

doi:10.3748/wjg.v27.i13.1296

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 13

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7877)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

493

WORD

208

HTML

4659

Figures (1-2)

296

Tables (1-2)

261

Sum=5917

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

293

Download

441

Sum=734

Publishing Process of This Article

Item

Count

Browse

443

Download

783

Sum=1226

Apr 7, 2021 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Apr 7, 2021; 27(13): 1296-1310
Published online Apr 7, 2021. doi: 10.3748/wjg.v27.i13.1296

Full Size Figure Download Figure

Figure 2 Severe acute respiratory syndrome-coronavirus type 2-associated pathogenesis and immunological response in the liver. ACE2: Angiotensin-converting enzyme 2; HBV: Hepatitis B virus; HCC: Hepatocellular carcinoma; HCV: Hepatitis C virus; IFN: Interferon; IL: Interleukin.; MAFLD: Metabolic associated fatty liver disease; NAFLD: Nonalcoholic fatty liver disease; NASH: Nonalcoholic steatohepatitis; SARS-CoV-2: Severe acute respiratory syndrome-coronavirus type 2; TNF: Tumor necrosis factor.

Citation: Ahmad A, Ishtiaq SM, Khan JA, Aslam R, Ali S, Arshad MI. COVID-19 and comorbidities of hepatic diseases in a global perspective. World J Gastroenterol 2021; 27(13): 1296-1310
URL: https://www.wjgnet.com/1007-9327/full/v27/i13/1296.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i13.1296